Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh

Asian semiconductor shares fell as mixed U.S. chipmaker results and doubts about returns on AI infrastructure spending weighed on the sector. Samsung fell 5.7%, SK Hynix 7.4%, Advantest more than 11%, Lasertec 12.5%, and Kioxia 9.2%; Qualcomm dropped more than 9% in extended trading after handset-chip revenue missed expectations, while Arm slipped about 3% despite beating quarterly revenue and earnings estimates. Chinese semiconductor shares mostly rose, supported by Beijing’s market-support measures.

Analysis

The key read-through is not simply weaker chip sentiment; it is a widening gap between AI spending and demonstrated monetization. ARM’s royalty growth lagging expectations raises a question about how quickly usage converts into licensable revenue, while SK hynix and test-equipment names carry greater sensitivity to data-center buildout expectations. QCOM’s handset miss is a separate, more conventional end-market risk: do not treat it as direct evidence that AI infrastructure demand is rolling over.

Near term, crowded AI-linked exposures may remain vulnerable to estimate cuts and multiple compression, especially where recent earnings guidance already disappointed. Over 1–3 months, watch memory pricing and supplier guidance, cloud-provider capex commentary, and whether AI project approvals face actual delays rather than political speculation. Over 6–18 months, sustained deployment could restore demand for memory and testing equipment; conversely, weak returns on customer investment would pressure orders before it materially affects reported revenue. China’s relative strength may reflect policy support and positioning, but policy-driven demand is not equivalent to durable earnings growth and may not offset restrictions on technology access.

Contrarian risk: the selloff may overgeneralize from QCOM handset weakness and ARM royalty growth, neither of which alone proves an AI capex downturn. Avoid chasing short exposure after large single-session declines; prefer waiting for revisions or a failed rebound.

Key Decisions for Investors

• Keep broad semiconductor exposure below benchmark pending clearer evidence that AI capex is translating into customer returns; reassess after the next round of hyperscaler capex commentary and supplier guidance.
• For a conditional relative-value trade, consider short SK hynix (SKHY) against long QCOM only if memory-price or SK hynix guidance estimates continue to fall while QCOM handset estimates stabilize. The thesis is relative earnings-revision risk, not that QCOM is immune to weakness. Exit if SK hynix revisions bottom and memory pricing strengthens, or if QCOM handset estimates deteriorate further.
• Do not initiate fresh shorts in Advantest or Lasertec solely on the reported one-day declines. Track order trends and guidance revisions; persistent weakness would support a broader cut to semiconductor test-equipment exposure, while stable orders would argue the move was positioning-driven.
• Treat Chinese semiconductor outperformance as a tactical policy-support signal, not yet a fundamental long. Verify whether support measures produce sustained order or earnings upgrades; fade the relative move if shares rise without corresponding estimate revisions.